Back to Journals » Drug Design, Development and Therapy » Volume 14

Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model Analysis

Total article views   HTML views PDF downloads Totals
9,598 Dovepress* 8,289+ 1,396 9,685
PubMed Central* 1,309 409 1,718
Totals 9,598 1,805 11,403
*Since 14 January 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed and Google Scholar